Entrada Therapeutics Inc — Liquidità Trimestrale (NASDAQ:TRDA) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Totale attivo 526.32 M486.48 M448.78 M412.9 M377.38 M Totale passività 97.64 M69.22 M69.28 M72.18 M71.25 M Patrimonio netto totale 428.68 M417.26 M379.5 M340.72 M306.13 M Totale passività e patrimonio netto 526.32 M486.48 M448.78 M412.9 M377.38 M Debito totale ————— Indebitamento netto —————

Notizie

Gli EPS di Entrada Therapeutics hanno battuto le aspettative per 0,04$, il fatturato appena sotto le previsioni

Entrada Therapeutics earnings beat by $0.04, revenue fell short of estimates

Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates

Repligen (RGEN) Tops Q4 Earnings and Revenue Estimates

Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline

EyePoint (EYPT) Surges 15.2%: Is This an Indication of Further Gains?

Illumina (ILMN) Tops Q4 Earnings and Revenue Estimates

Techne (TECH) Beats Q2 Earnings and Revenue Estimates

Entrada Therapeutics, Inc. (TRDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Capricor Therapeutics Stock: A High Risk/High Reward Name (NASDAQ:CAPR)

Entrada riporta progressi sui trattamenti DMD e condivide il calendario clinico

Entrada reports progress on DMD treatments, shares clinical timeline